ArticleHeliyon2025
The stability improvements of dye-sensitized solar cell with natural template for photoanode using lignin extracted from rice husk.
Article in Heliyon, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
Corrections and comments
- Erratum issued
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In response to escalating global concerns over environmental pollution, the development of green dye-sensitized solar cells (DSSCs) has emerged as a promising technology for solar energy conversion. This study harnesses the potential of rice husk, an abundant agricultural waste in Indonesia, by extracting lignin through a simple recycling method. Lignin acts as a natural, non-toxic dopant and template for TiO₂ composites, enhancing the stability of the photoanode in DSSCs. A TiO₂ photoanode modified with 5 % lignin achieved a power conversion efficiency (PCE) of 4.81 %. After a 90-day stability test, the TiO
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.